Analyst Recommendations
25.15 0.25(1.00%)07/03/2024
Genmab (GMAB)
Genmab (GMAB)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 15 |
Outperform | 1 |
Underweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades